| Date Filed | Type | Description |
| 12/07/2021 |
SC 13D/A
| BAY CITY CAPITAL LLC reports a 11.9% stake in Madrigal Pharmaceuticals, Inc. |
| 12/07/2021 |
4
| BAY CITY CAPITAL LLC (10% Owner) has filed a Form 4 on MADRIGAL PHARMACEUTICALS, INC.|
Txns:
| Disposed of 750,270 shares
@ $0
Disposed of 49,730 shares
@ $0
Disposed of 24,172 shares
@ $0 |
|
| 10/26/2021 |
4
| BAY CITY CAPITAL LLC (10% Owner) has filed a Form 4 on Xilio Therapeutics, Inc.|
Txns:
| Converted 665,696 shares
@ $0
Converted 151,294 shares
@ $0
Bought 312,500 shares
@ $16, valued at
$5M
Converted 6,324,110 preferred shares
@ $0
Converted 1,437,297 preferred shares
@ $0 |
|
| 10/21/2021 |
3
| BAY CITY CAPITAL LLC (10% Owner) has filed a Form 3 on Xilio Therapeutics, Inc. |
| 12/01/2020 |
4
| BAY CITY CAPITAL LLC (10% Owner) has filed a Form 4 on MADRIGAL PHARMACEUTICALS, INC.|
Txns:
| Disposed of 43,537 shares
@ $0 |
|
| 09/04/2020 |
SC 13D/A
| BAY CITY CAPITAL LLC reports a 18.6% stake in Madrigal Pharmaceuticals, Inc. |
| 09/04/2020 |
4
| BAY CITY CAPITAL LLC (10% Owner) has filed a Form 4 on MADRIGAL PHARMACEUTICALS, INC.|
Txns:
| Acquired 1,468,350 shares
@ $0
Acquired 31,650 shares
@ $0
Acquired 45,460 shares
@ $0 |
|
| 08/19/2020 |
4
| BAY CITY CAPITAL LLC (10% Owner) has filed a Form 4 on MADRIGAL PHARMACEUTICALS, INC.|
Txns:
| Sold 12,500 shares
@ $110.73, valued at
$1.4M
Sold 10,197 shares
@ $110.03, valued at
$1.1M
Sold 7,303 shares
@ $107.64, valued at
$786.1k
|
|
| 06/01/2020 |
SC 13D/A
| BAY CITY CAPITAL LLC reports a 27.9% stake in Madrigal Pharmaceuticals, Inc. |
| 05/29/2020 |
4
| BAY CITY CAPITAL LLC (10% Owner) has filed a Form 4 on MADRIGAL PHARMACEUTICALS, INC.|
Txns:
| Acquired 360,561 shares
@ $0
Acquired 6,772 shares
@ $0
Acquired 44,903 shares
@ $0 |
|
| 03/16/2020 |
4
| GOLDFISCHER CARL (10% Owner) has filed a Form 4 on IMARA Inc.|
Txns:
| Converted 690,232 shares
@ $0
Converted 13,148 shares
@ $0
Converted 281,878 options to buy
@ $0
Converted 5,372 options to buy
@ $0
Converted 3,220,915 preferred shares
@ $0
Converted 61,378 preferred shares
@ $0
Converted 845,008 preferred shares
@ $0
Converted 16,103 preferred shares
@ $0
Granted 15,457 options to buy
@ $16, valued at
$247.3k
|
|
| 03/16/2020 |
4
| BAY CITY CAPITAL LLC (10% Owner) has filed a Form 4 on IMARA Inc.|
Txns:
| Converted 690,232 shares
@ $0
Converted 13,148 shares
@ $0
Converted 281,878 options to buy
@ $0
Converted 5,372 options to buy
@ $0
Converted 3,220,915 preferred shares
@ $0
Converted 61,378 preferred shares
@ $0
Converted 845,008 preferred shares
@ $0
Converted 16,103 preferred shares
@ $0
Granted 15,457 options to buy
@ $16, valued at
$247.3k
|
|
| 03/11/2020 |
3
| BAY CITY CAPITAL LLC (10% Owner) has filed a Form 3 on IMARA Inc. |
| 02/24/2020 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 01/13/2020 |
SC 13D/A
| BAY CITY CAPITAL LLC reports a 6.5% stake in Dermira, Inc. |
| 12/13/2019 |
SC 13D/A
| BAY CITY CAPITAL LLC reports a 27.1% stake in Madrigal Pharmaceuticals, Inc. |
| 12/13/2019 |
4
| BAY CITY CAPITAL LLC (10% Owner) has filed a Form 4 on MADRIGAL PHARMACEUTICALS, INC.|
Txns:
| Sold 1,174,680 shares
@ $105.47, valued at
$123.9M
Sold 25,320 shares
@ $105.47, valued at
$2.7M
|
|
| 10/17/2019 |
SC 13D/A
| BAY CITY CAPITAL LLC reports a 34.8% stake in Madrigal Pharmaceuticals, Inc. |
| 11/28/2018 |
SC 13D/A
| BAY CITY CAPITAL LLC reports a 9.3% stake in Merus N.V. |
| 06/28/2018 |
4
| BAY CITY CAPITAL LLC (10% Owner) has filed a Form 4 on Kezar Life Sciences, Inc.|
Txns:
| Converted 472,229 shares
@ $0
Bought 150,000 shares
@ $15, valued at
$2.3M
Converted 472,229 options to buy
@ $0 |
|
| 06/20/2018 |
3
| BAY CITY CAPITAL LLC (10% Owner) has filed a Form 3 on Kezar Life Sciences, Inc. |
| 06/12/2018 |
4
| BAY CITY CAPITAL LLC (10% Owner) has filed a Form 4 on MADRIGAL PHARMACEUTICALS, INC.|
Txns:
| Sold 274,092 shares
@ $287.46, valued at
$78.8M
Sold 5,908 shares
@ $287.46, valued at
$1.7M
|
|
| 02/10/2017 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 09/02/2016 |
SC 13G/A
| NEVRO CORP reports a 2.5% stake in Nevro Corp. |
| 08/05/2016 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership [Amend] |
| 08/02/2016 |
4
| BAY CITY CAPITAL LLC (10% Owner) has filed a Form 4 on INTERLEUKIN GENETICS INC |
| 07/29/2016 |
SC 13D
| Madrigal Pharmaceuticals, Inc. reports a 49.9% stake in Madrigal Pharmaceuticals, Inc. |
| 07/26/2016 |
3
| BAY CITY CAPITAL LLC (10% Owner) has filed a Form 3 on SYNTA PHARMACEUTICALS CORP |
| 05/27/2016 |
SC 13D
| Merus B.V. reports a 13.1% stake in Merus N.V. |
| 01/12/2016 |
4
| BAY CITY CAPITAL LLC (10% Owner) has filed a Form 4 on Epizyme, Inc. |
| 07/28/2015 |
4
| BAY CITY CAPITAL LLC (10% Owner) has filed a Form 4 on SUNESIS PHARMACEUTICALS INC |
| 06/17/2015 |
4
| BAY CITY CAPITAL LLC (Former 10% Beneficial Owner) has filed a Form 4 on NEVRO CORP |
| 12/24/2014 |
4
| BAY CITY CAPITAL LLC (10% Owner) has filed a Form 4 on INTERLEUKIN GENETICS INC |
| 11/12/2014 |
4
| BAY CITY CAPITAL LLC (Former 10% Beneficial Owner) has filed a Form 4 on NEVRO CORP |
|